Request Demo
Recent blog posts
Latest Hotspot
8 min read
TARM1 Biologics Sequence Review Report 2026: T-cell-interacting, activating receptor on myeloid cells protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TARM1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TACR3 Biologics Sequence Review Report 2026: Neuromedin-K receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TACR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TACR1 Biologics Sequence Review Report 2026: Substance-P receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TACR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TACR2 Biologics Sequence Review Report 2026: Substance-K receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TACR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TAAR5 Biologics Sequence Review Report 2026: Trace amine-associated receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TAAR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SSTR4 Biologics Sequence Review Report 2026: Somatostatin receptor type 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SSTR5 Biologics Sequence Review Report 2026: Somatostatin receptor type 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SSTR3 Biologics Sequence Review Report 2026: Somatostatin receptor type 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SSTR1 Biologics Sequence Review Report 2026: Somatostatin receptor type 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SCTR Biologics Sequence Review Report 2026: Secretin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SCTR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
RAMP2 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
RAMP3 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.